SCYNEXIS
SCYX
$2.24
Share price
-2.39%
Change (1 day)
-8.02%
Change (1 year)
Categories
SCYNEXIS (SCYX) - Total assets
Total assets on the balance sheet as of March 2024 : $0.11 B
According to SCYNEXIS's latest financial reports the company's total assets are $0.11 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
SCYNEXIS - Total assets on balance sheet (from 2013 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $87.81 M | -26.73% |
| 2021-12-31 | $0.11 B | 16.87% |
| 2020-12-31 | $0.10 B | 79.41% |
| 2019-12-31 | $57.15 M | 7.49% |
| 2018-12-31 | $53.17 M | 15.97% |
| 2017-12-31 | $45.85 M | -23.32% |
| 2016-12-31 | $59.79 M | 21.35% |
| 2015-12-31 | $49.27 M | 24.2% |
| 2014-12-31 | $39.67 M | 220.27% |
| 2013-12-31 | $12.38 M | 2.22% |
| 2012-12-31 | $12.11 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Galmed Pharmaceuticals
GLMD | $16.62 M | -85.94% | 🇮🇱 Israel |
 Catalyst Pharmaceuticals CPRX | $0.64 B | 446.85% | 🇺🇸 USA |
 Catalent CTLT | $9.87 B | 8,254.05% | 🇺🇸 USA |
 KemPharm KMPH | $0.11 B | -2.30% | 🇺🇸 USA |